Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice
- 1 September 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (17), 1447-1457
- https://doi.org/10.1038/sj.gt.3301261
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 53 references indexed in Scilit:
- Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expressionGene Therapy, 1997
- Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNAGene Therapy, 1997
- Do DNA Vaccines Induce Autoimmune Disease?Human Gene Therapy, 1997
- DNA vaccinesLife Sciences, 1996
- Gene therapy in Duchenne muscular dystrophyBrain & Development, 1996
- Quantitative Estimation of Dystrophin Protein: A Sensitive and Convenient "Two-Antibody Sandwich" ELISA.The Tohoku Journal of Experimental Medicine, 1996
- Coisogenic All-Plus-One Immunization: A Model for Identifying Missing Proteins in Null-Mutant Conditions. Antibodies to Dystrophin in mdx Mouse After Transplantation of Muscle from Normal Coisogenic DonorNeuropediatrics, 1994
- Myoblast transfer in duchenne muscular dystrophyAnnals of Neurology, 1993
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequencesNature, 1981